Form 8-K - Current report:
SEC Accession No. 0001193125-24-032859
Filing Date
2024-02-13
Accepted
2024-02-13 06:55:35
Documents
48
Period of Report
2024-02-13
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d785380d8k.htm   iXBRL 8-K 32031
2 EX-99.1 d785380dex991.htm EX-99.1 32889
3 EX-99.2 d785380dex992.htm EX-99.2 17153
7 GRAPHIC g785380ex99_1p10g1.jpg GRAPHIC 215635
8 GRAPHIC g785380ex99_1p11g1.jpg GRAPHIC 225590
9 GRAPHIC g785380ex99_1p12g1.jpg GRAPHIC 166491
10 GRAPHIC g785380ex99_1p13g1.jpg GRAPHIC 103765
11 GRAPHIC g785380ex99_1p14g1.jpg GRAPHIC 187249
12 GRAPHIC g785380ex99_1p15g1.jpg GRAPHIC 247900
13 GRAPHIC g785380ex99_1p16g1.jpg GRAPHIC 158433
14 GRAPHIC g785380ex99_1p17g1.jpg GRAPHIC 137624
15 GRAPHIC g785380ex99_1p18g1.jpg GRAPHIC 174197
16 GRAPHIC g785380ex99_1p19g1.jpg GRAPHIC 215109
17 GRAPHIC g785380ex99_1p1g1.jpg GRAPHIC 91947
18 GRAPHIC g785380ex99_1p20g1.jpg GRAPHIC 168409
19 GRAPHIC g785380ex99_1p21g1.jpg GRAPHIC 164701
20 GRAPHIC g785380ex99_1p22g1.jpg GRAPHIC 190017
21 GRAPHIC g785380ex99_1p23g1.jpg GRAPHIC 212294
22 GRAPHIC g785380ex99_1p24g1.jpg GRAPHIC 110566
23 GRAPHIC g785380ex99_1p25g1.jpg GRAPHIC 217189
24 GRAPHIC g785380ex99_1p26g1.jpg GRAPHIC 142050
25 GRAPHIC g785380ex99_1p27g1.jpg GRAPHIC 219393
26 GRAPHIC g785380ex99_1p28g1.jpg GRAPHIC 145886
27 GRAPHIC g785380ex99_1p29g1.jpg GRAPHIC 58297
28 GRAPHIC g785380ex99_1p2g1.jpg GRAPHIC 363503
29 GRAPHIC g785380ex99_1p30g1.jpg GRAPHIC 214042
30 GRAPHIC g785380ex99_1p31g1.jpg GRAPHIC 153350
31 GRAPHIC g785380ex99_1p32g1.jpg GRAPHIC 65496
32 GRAPHIC g785380ex99_1p3g1.jpg GRAPHIC 205348
33 GRAPHIC g785380ex99_1p4g1.jpg GRAPHIC 146457
34 GRAPHIC g785380ex99_1p5g1.jpg GRAPHIC 77673
35 GRAPHIC g785380ex99_1p6g1.jpg GRAPHIC 168557
36 GRAPHIC g785380ex99_1p7g1.jpg GRAPHIC 201416
37 GRAPHIC g785380ex99_1p8g1.jpg GRAPHIC 76229
38 GRAPHIC g785380ex99_1p9g1.jpg GRAPHIC 143200
  Complete submission text file 0001193125-24-032859.txt   7623138

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA kalv-20240213.xsd EX-101.SCH 2854
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE kalv-20240213_lab.xml EX-101.LAB 17995
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kalv-20240213_pre.xml EX-101.PRE 11264
49 EXTRACTED XBRL INSTANCE DOCUMENT d785380d8k_htm.xml XML 3648
Mailing Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Filer) CIK: 0001348911 (see all company filings)

EIN.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-36830 | Film No.: 24622541
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)